Paper Details

  1. Home
  2. Paper Details

Adjuvant Human Papillomavirus Vaccination for Secondary Prevention: A Systematic Review.

Author: AminMilan R, BoydLeslie R, BranskiRyan C, DionGregory R, Mason-AppsCharlotte, NorthamAntonia, TengStephanie, VieiraDorice

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

While HPV vaccination is recommended for children and young adults, older adults and those who have already been exposed to HPV remain at risk. New research suggests that vaccination might be helpful as an additional treatment for people with HPV-related diseases.
Paper Details　
Original Abstract of the Article :
Human papillomavirus (HPV) vaccination is recommended for children and younger adults but not older adults or those with prior HPV exposure, leaving a large portion of the population at risk for HPV-mediated disease. Emerging data suggest a possible role for vaccination as an adjuvant treatment for ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1001/jamaoto.2016.4736

データ提供：米国国立医学図書館（NLM）

Exploring the Potential of Adjuvant HPV Vaccination for Secondary Prevention

Human papillomavirus (HPV) is a ubiquitous virus that can cause a range of health problems, including cervical cancer, genital warts, and other malignancies. Vaccination against HPV is widely recommended for children and young adults, but it is not typically offered to older individuals or those who have already been exposed to HPV. This research explores the potential of HPV vaccination as an adjuvant treatment, meaning it could be used in conjunction with other therapies, for individuals who have already developed HPV-related clinical disease.

The study, a systematic review of existing research, examines the emerging evidence suggesting a potential role for HPV vaccination in secondary prevention. The researchers analyze the effectiveness of vaccination in individuals with pre-existing HPV infections and HPV-related diseases, seeking to determine if vaccination can help to prevent disease progression and improve outcomes.

Expanding the Reach of HPV Vaccination

This research holds exciting possibilities for expanding the reach of HPV vaccination. The study suggests that vaccination, even in individuals who have already been exposed to HPV, could be a valuable tool in preventing and managing HPV-related diseases. This could lead to more comprehensive and effective HPV prevention strategies, potentially benefiting a wider range of individuals.

The Importance of Continuous HPV Research

This research emphasizes the ongoing need for research into the potential of HPV vaccination for secondary prevention. Understanding the effectiveness of vaccination in individuals with pre-existing HPV infections is crucial for developing targeted and effective public health interventions. This research, like a compass guiding us through the complexities of HPV infection, could lead to a more robust and comprehensive approach to preventing and managing HPV-related diseases.

Dr.Camel's Conclusion

The journey towards preventing HPV-related diseases is an ongoing one. This research, like a desert oasis, offers valuable insights into the potential of HPV vaccination for individuals who have already been exposed to the virus. Further exploration of this avenue, guided by careful scientific investigation, could lead to a wider and more effective approach to preventing and managing HPV-related health issues.

Date :
  1. Date Completed 2017-08-21
  2. Date Revised 2023-09-18
Further Info :

Pubmed ID

28334393

DOI: Digital Object Identifier

10.1001/jamaoto.2016.4736

Related Literature

Article Analysis
・Effective treatment of hpv
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.